OTC · Dividend
Gene Biotherapeutics, Inc. (CRXM) Dividend
$0.00
OTC: CRXM
Market Cap $6493
Dividend Analysis
Gene Biotherapeutics, Inc. (CRXM) does not currently pay a dividend. Companies typically skip dividends to reinvest earnings into growth, R&D, or debt paydown instead of returning cash to shareholders.